• Trusted. Nationwide. Personalized.

Follow Us

Nationwide Compounding Logo
  • (877) 396-7313

Latest News2026-07-28T17:54:09+00:00

The Latest in Compounding.
Made Relevant.

Stay informed with the latest news, insights, and updates in the world of compounding pharmacy and personalized medicine.

Personalized Medicine.
Made for You.

Compounding is the art and science of creating custom medications tailored to meet the unique needs of each patient.

The Latest in Compounding.
Made Relevant.

Stay informed with the latest news, insights, and updates in the world of compounding pharmacy and personalized medicine.

Industry Insights

Expert perspectives on trends, advances, and the future of compounding pharmacy.

Clinical Updates

Evidence-based information on therapies, ingredients, and formulation innovations.

Company News

Announcements, partnerships, and the latest from nationwide Compounding RX.

Education & Resources

Helpful articles and patient education to support better health outcomes.

The power of personalization

What is Compounding?

Benefits of Compounding

Compounding is a specialized process in which a licensed pharmacist creates a medicine tailored specifically for a patient’s individual needs. When commercially available medications don’t meet a patient’s unique requirements, compounding offers a personalized solution.

Industry Insights

Expert perspectives on trends, advances, and the future of compounding pharmacy.

Clinical Updates

Evidence-based information on therapies, ingredients, and formulation innovations.

Company News

Announcements, partnerships, and the latest from nationwide Compounding RX.

Education & Resources

Helpful articles and patient education to support better health outcomes.

Compounding Pharmacy Consultation for Prescribers: The Pre-Prescription Clinical Dialogue That Protects Patients and Reduces Liability in 2026

August 3rd, 2026|

Most prescribers skip the pre-prescription clinical dialogue with compounding pharmacists—a gap with serious compliance and liability consequences in 2026. A structured compounding pharmacy consultation for prescribers is now the critical first step in the prescribing workflow. Discover what it includes, when it's required, and how it protects both patients and practitioners.

Medical Appetite Suppressant Compounding: Beyond GLP-1 in 2026

August 3rd, 2026|

GLP-1 medications dominate headlines, but medical appetite suppressant compounding in 2026 offers a far broader landscape than most prescribers and patients realize. From custom-dosed phentermine combinations to peptide-based options, legally accessible 503A compounding remains robust and clinically sophisticated. This guide covers the full spectrum of compoundable weight management therapies available today.

Compounded Pain Cream vs Oral Pain Medication: The Honest 2026 Clinical Comparison

August 3rd, 2026|

Choosing between compounded pain cream and oral pain medication isn't straightforward—the right answer depends on your pain type, patient profile, and formulation quality. This honest 2026 clinical comparison weighs the real pharmacokinetic advantages of topical delivery against its limitations, including key randomized controlled trial data. Get the evidence-based guidance you need to make an informed decision.

Lip Balm Medication Compounding Pharmacy: The Clinical Guide to Medicated Stick Formulations in 2026

July 31st, 2026|

A lip balm medication compounding pharmacy can formulate prescription-strength medicated sticks tailored to each patient's exact clinical needs—something no off-the-shelf product can match. This clinical guide covers active ingredients, mechanisms of action, regulatory requirements, and beyond-use dating for compounded lip formulations in 2026. Whether treating recurrent cold sores or managing sensitivity reactions, custom medicated lip balms offer a precise, personalized alternative.

Medical Weight Loss Medication Compounding: The 2026 Clinic Partnership Playbook

July 31st, 2026|

The 2026 regulatory landscape has fundamentally reshaped medical weight loss medication compounding, with the FDA moving to exclude semaglutide and tirzepatide from the 503B Bulks List. This clinic partnership playbook covers compliant pharmacy vetting, 503A clinical justification workflows, and the operational infrastructure needed to build a sustainable, scalable weight loss practice. Access alone no longer drives success—clinical systems do.

High-Quality Compounding

Easy Prescribing

Nationwide Delivery

Practice Support

Questions or Topics You’d Like Us to Cover?

We welcome topic suggestions and feedback to help us bring you the most relevant information.

Go to Top